Randy A. Brown

Phase III Randomized Multicenter Study of a Humanized Anti-CD33 Monoclonal Antibody, Lintuzumab, in Combination With Chemotherapy, Versus Chemotherapy Alone in Patients With Refractory or First-Relapsed Acute Myeloid Leukemia

Eric J. Feldman, Joseph Brandwein, Richard M. Stone et al. · Journal of Clinical Oncology · 2005 · 249 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Sudden death among patients with acute promyelocytic leukemia treated with arsenic trioxide

Peter Westervelt, Randy A. Brown, Douglas R. Adkins et al. · Blood · 2001 · 248 citations

Medicine, Hematology, Oncology +12

Purging of Autologous Peripheral-Blood Stem Cells Using CD34 Selection Does Not Improve Overall or Progression-Free Survival After High-Dose Chemotherapy for Multiple Myeloma: Results of a Multicenter Randomized Controlled Trial

A. Keith Stewart, Robert Vescio, Gary J. Schiller et al. · Journal of Clinical Oncology · 2001 · 199 citations

Medicine, Hematology, Oncology +17

Multicenter phase III trial to evaluate CD34(+) selected versus unselected autologous peripheral blood progenitor cell transplantation in multiple myeloma.

Robert Vescio, Gary J. Schiller, A. Keith Stewart et al. · PubMed · 1999 · 172 citations

Medicine, Hematology, Oncology +12

A randomized phase 3 study of peripheral blood progenitor cell mobilization with stem cell factor and filgrastim in high-risk breast cancer patients.

Elizabeth J. Shpall, Catherine Wheeler, Stewart A. Turner et al. · PubMed · 1999 · 103 citations

Medicine, Oncology, Cell Therapy +9